Ivermectinobservational2004

Predictors for compliance with community directed ivermectin treatment in Bushenyi district of Uganda: qualitative results.

East African medical journal

confidence

Key findings

Qualitative study identifying factors influencing compliance with community-directed ivermectin treatment for onchocerciasis; no clinical/biological endpoints measured.

View source on PubMed (PMID 15125093) ↗

Sample size
50 key informants; 5 focus group discussions with community members
Population
Community members and key informants (local council chairpersons and community directed drug distributors) in Bushenyi district, Uganda
Dosing
not_reported
Duration
not_reported
Route
oral
Blinding
not_reported
Controls
none
Drug class
antiparasitic
Full abstract

To understand and elicit the factors influencing compliance with mass treatment with ivermectin for onchocerciasis control with a view of suggesting remedial measures. Qualitative methods using focus group discussion and individual key informant interviews. Bushenyi district, Uganda. Fifty key informants who were local council chairpersons and community directed drug distributors (CDDs) for ivermectin. Five focus group discussions with community members. Explored knowledge about onchocerciasis and its treatment, consequences, benefits and perceived dangers of treatment with ivermectin. In addition the FGDs elicited information regarding social influence towards ivermectin treatment and who the source of social influences are. Perceived barriers and supports towards ivermectin treatment were also explored. The key informant interviews mainly elicited the problems they face in ivermectin distribution and their suggestions for improvement. Factors that could possibly influence mass treatment with ivermectin that were elicited include consequences of treatment, programme organization, charging for ivermectin distribution and programme/community support to the ivermectin drug distributors. These results are helpful in redirecting community education and in helping to design further quantitative research.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.